The Emerging and Diverse Roles of Sirtuins in Cancer: a Clinical Perspective

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2013 Oct 18

PMID 24133372

Citations 98

Authors

Hongfeng Yuan

Leila Su

Wen Yong Chen

Affiliations

Soon will be listed here.

Abstract

Sirtuins are a highly conserved family of nicotinamide adenine dinucleotide (NAD(+))-dependent protein lysine modifying enzymes with deacetylase, adenosine diphosphateribosyltransferase and other deacylase activities. Mammals have seven sirtuins, namely SIRT1-7. They are key regulators for a wide variety of cellular and physiological processes such as cell proliferation, differentiation, DNA damage and stress response, genome stability, cell survival, metabolism, energy homeostasis, organ development, aging, and cancer. Here we present an extensive literature review of the roles of mammalian sirtuins, particularly SIRT1 as that is the most studied sirtuin, in human epithelial, neuronal, hematopoietic, and mesenchymal malignancies, covering breast, prostate, lung, thyroid, liver, colon, gastric, pancreatic, ovarian, and cervical cancers, tumors of the central nervous system, leukemia and lymphoma, and soft tissue sarcomas. Collective evidence suggests sirtuins are involved in both promoting and suppressing tumorigenesis depending on cellular and molecular contexts. We discuss the potential use of sirtuin modulators, especially sirtuin inhibitors, in cancer treatment.

Citing Articles

Sirtuin Proteins and Memory: A Promising Target in Alzheimer's Disease Therapy?.

Fernandez F, Griffiths L, Sutherland H, Cole M, Fitton J, Winberg P Nutrients. 2024; 16(23).

PMID: 39683482 PMC: 11644011. DOI: 10.3390/nu16234088.

SIRT2 Inhibition by AGK2 Promotes Perinuclear Cytoskeletal Organisation and Reduces Invasiveness of MDA-MB-231 Triple-Negative Breast Cancer Cells in Confined In Vitro Models.

Jessop E, Young N, Garcia-Del-Valle B, Crusher J, Obara B, Karakesisoglou I Cells. 2024; 13(23).

PMID: 39682770 PMC: 11639776. DOI: 10.3390/cells13232023.

Targeting sirtuins for cancer therapy: epigenetics modifications and beyond.

Shen H, Qi X, Hu Y, Wang Y, Zhang J, Liu Z Theranostics. 2024; 14(17):6726-6767.

PMID: 39479446 PMC: 11519805. DOI: 10.7150/thno.100667.

Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies.

Zarrabi A, Perrin D, Kavoosi M, Sommer M, Sezen S, Mehrbod P Cancers (Basel). 2023; 15(21).

PMID: 37958442 PMC: 10650215. DOI: 10.3390/cancers15215269.

Propofol inhibits colon cancer cell stemness and epithelial-mesenchymal transition by regulating SIRT1, Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways.

Wang R, Li S, Hou Q, Zhang B, Chu H, Hou Y Discov Oncol. 2023; 14(1):137.

PMID: 37490168 PMC: 10368601. DOI: 10.1007/s12672-023-00734-y.

References

Roth M, Chen W . Sorting out functions of sirtuins in cancer. Oncogene. 2013; 33(13):1609-20. PMC: 4295628. DOI: 10.1038/onc.2013.120. View

Sundaresan N, Pillai V, Wolfgeher D, Samant S, Vasudevan P, Parekh V . The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy. Sci Signal. 2011; 4(182):ra46. DOI: 10.1126/scisignal.2001465. View

Kanfi Y, Naiman S, Amir G, Peshti V, Zinman G, Nahum L . The sirtuin SIRT6 regulates lifespan in male mice. Nature. 2012; 483(7388):218-21. DOI: 10.1038/nature10815. View

Hirschey M, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard D . SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature. 2010; 464(7285):121-5. PMC: 2841477. DOI: 10.1038/nature08778. View

Alhazzazi T, Kamarajan P, Joo N, Huang J, Verdin E, DSilva N . Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer. 2011; 117(8):1670-8. PMC: 3117020. DOI: 10.1002/cncr.25676. View

Arrowsmith C, Bountra C, Fish P, Lee K, Schapira M . Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov. 2012; 11(5):384-400. DOI: 10.1038/nrd3674. View

Kang H, Suh J, Jung Y, Jung J, Kim M, Chung J . Peptide switch is essential for Sirt1 deacetylase activity. Mol Cell. 2011; 44(2):203-13. PMC: 3240942. DOI: 10.1016/j.molcel.2011.07.038. View

Hallows W, Lee S, Denu J . Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci U S A. 2006; 103(27):10230-10235. PMC: 1480596. DOI: 10.1073/pnas.0604392103. View

Liszt G, Ford E, Kurtev M, Guarente L . Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J Biol Chem. 2005; 280(22):21313-20. DOI: 10.1074/jbc.M413296200. View

10.

Zuo Q, Wu W, Li X, Zhao L, Chen W . HDAC6 and SIRT2 promote bladder cancer cell migration and invasion by targeting cortactin. Oncol Rep. 2011; 27(3):819-24. DOI: 10.3892/or.2011.1553. View

11.

Shore D, Squire M, Nasmyth K . Characterization of two genes required for the position-effect control of yeast mating-type genes. EMBO J. 1984; 3(12):2817-23. PMC: 557771. DOI: 10.1002/j.1460-2075.1984.tb02214.x. View

12.

Liu Y, Dentin R, Chen D, Hedrick S, Ravnskjaer K, Schenk S . A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature. 2008; 456(7219):269-73. PMC: 2597669. DOI: 10.1038/nature07349. View

13.

Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C, Kreppel F . SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell. 2008; 134(2):317-28. DOI: 10.1016/j.cell.2008.06.050. View

14.

Wu M, Wei W, Xiao X, Guo J, Xie X, Li L . Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer. Med Oncol. 2012; 29(5):3240-9. DOI: 10.1007/s12032-012-0260-6. View

15.

Cho I, Koh S, Malilas W, Srisuttee R, Moon J, Choi Y . SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of β-catenin. Biochem Biophys Res Commun. 2012; 423(2):270-5. DOI: 10.1016/j.bbrc.2012.05.107. View

16.

Peng C, Lu Z, Xie Z, Cheng Z, Chen Y, Tan M . The first identification of lysine malonylation substrates and its regulatory enzyme. Mol Cell Proteomics. 2011; 10(12):M111.012658. PMC: 3237090. DOI: 10.1074/mcp.M111.012658. View

17.

Nasrin N, Wu X, Fortier E, Feng Y, Bare O, Chen S . SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J Biol Chem. 2010; 285(42):31995-2002. PMC: 2952200. DOI: 10.1074/jbc.M110.124164. View

18.

Rothgiesser K, Erener S, Waibel S, Luscher B, Hottiger M . SIRT2 regulates NF-κB dependent gene expression through deacetylation of p65 Lys310. J Cell Sci. 2010; 123(Pt 24):4251-8. DOI: 10.1242/jcs.073783. View

19.

Pan P, Feldman J, Devries M, Dong A, Edwards A, Denu J . Structure and biochemical functions of SIRT6. J Biol Chem. 2011; 286(16):14575-87. PMC: 3077655. DOI: 10.1074/jbc.M111.218990. View

20.

Nakahata Y, Kaluzova M, Grimaldi B, Sahar S, Hirayama J, Chen D . The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell. 2008; 134(2):329-40. PMC: 3526943. DOI: 10.1016/j.cell.2008.07.002. View